Related Experiment Video
Updated: May 22, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
One community's effort to control genetic disease
Kevin A Strauss1, Erik G Puffenberger, D Holmes Morton
1Clinic for Special Children, Strasburg, PA17579, USA. kstrauss@clinicforspecialchildren.org
Community health clinics can significantly reduce medical costs for genetic disorders by leveraging molecular data and technology. Implementing existing knowledge effectively, rather than scientific advancement, is key to improving patient outcomes.
Area of Science:
- Medical Genetics
- Community Health
- Health Services Research
Background:
- Established a community health clinic in 1989 serving uninsured Amish and Mennonite children with genetic disorders.
- Focus on providing care for underserved populations with complex health needs.
Purpose of the Study:
- To assess the impact of utilizing molecular data and advanced technologies in a community health setting.
- To evaluate the cost-effectiveness and clinical benefits of specialized care for genetic disorders.
Main Methods:
- Employed publicly available molecular data and sophisticated diagnostic technologies.
- Tracked improvements in diagnostic efficiency, laboratory costs, hospitalizations, and neurological impairments.
- Analyzed clinic's operating budget and estimated aggregate medical cost savings for local communities.
Main Results:
- Over two decades, the clinic significantly improved diagnostic efficiency and reduced costs.
- Prevented major neurological impairments in children with genetic disorders.
- The clinic's $1.5 million budget in 2010 generated an estimated $20-25 million in aggregate medical cost savings.
Conclusions:
- The primary barrier to improving outcomes for genetic diseases is not scientific knowledge or cost, but the implementation of existing resources.
- Community-based models utilizing advanced technology can be highly effective and cost-efficient.
- Strategic resource allocation is crucial for maximizing the impact of healthcare interventions in underserved populations.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
What is Genetic Engineering?
Pharmacogenomics: Identification of New Drug Targets
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genomics

